Pengyang Li
Advanced Heart Failure and Transplant Cardiology · Richmond, VANPI 1972080224
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,728 of the $4,307 with a category attached, or 63.4%. 19 manufacturers reported payments, led by Abbott at 48.3% of the total. Reporting peaked in 2023 at $1,822 and has fallen 61.2% since, to $706 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in VA, where the typical reported total is $4,498.
Across 75 payments — averaging $57.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Abiomed$641
- AstraZeneca$371
- Cvrx, Inc.$282
- Pfizer$183
- Boston Scientific$107
- plus $643 from 13 others
What the payments were for
- Travel & lodging$1,02524%
- Food & beverage$2,72863%
- Education$55313%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $2,079 |
| Abiomed | 10 | $641 |
| AstraZeneca(2 entities) | 15 | $371 |
| Cvrx, Inc. | 3 | $282 |
| Pfizer | 7 | $183 |
| Boston Scientific | 1 | $107 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $96 |
| Johnson & Johnson | 4 | $88 |
| Bayer | 2 | $82 |
| Alnylam Pharmaceuticals Inc. | 1 | $75 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Boehringer Ingelheim | 3 | $45 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Novartis | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| AbbVie | 1 | $24 |
| Shire North American Group Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,307 in reported general payments places this provider in the 45th percentile of 43 advanced heart failure and transplant cardiology providers in Virginia.
See all advanced heart failure and transplant cardiology providers in Virginia →
Other advanced heart failure and transplant cardiology in Richmond
- Edward SaweyRichmond$35K
- Lavone SmithRichmond$23K
- Neil LewisRichmond$9K
- Melissa SmallfieldRichmond$5K
- Inna TchoukinaRichmond$3K
- Nimesh PatelRichmond$2K
- Kelli FoxRichmond$2K
- Krishnasree RaoRichmond$605
- Anit MankadRichmond$425
- Sasa MitrovicRichmond$139
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.